Market Place
Sourcing Support
Withdrawal of marketing authorisations for fenspiride medicines
29 May 2019 //
EMA
EMA’s PRAC Calls for Withdrawal of Fenspiride CoughMedicines,Restrict on Xeljanz
23 May 2019 //
RAPS
Withdrawal of marketing authorisations for fenspiride medicines
18 May 2019 //
EMA
EMA suspends fenspiride medicines due to heart rhythm risks
19 Feb 2019 //
PHARMA TIMES
Meeting highlights from PV Risk Assessment Committee 11-14 Feb 2019
15 Feb 2019 //
EMA
Suspension of fenspiride medicines due to risk of heart rhythm problems
15 Feb 2019 //
EMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.